Amedisys (AMED) Competitors

Addus HomeCare (NASDAQ:ADUS) and Amedisys (NASDAQ:AMED) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations.

Which has more risk & volatility, ADUS or AMED?

Addus HomeCare has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500. Comparatively, Amedisys has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500.

Is ADUS or AMED more profitable?

Addus HomeCare has a net margin of 6.50% compared to Amedisys' net margin of 3.57%. Amedisys' return on equity of 12.20% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	6.50%	9.62%	7.37%
Amedisys	3.57%	12.20%	6.74%

Do insiders and institutionals have more ownership in ADUS or AMED?

95.4% of Addus HomeCare shares are held by institutional investors. Comparatively, 94.4% of Amedisys shares are held by institutional investors. 4.6% of Addus HomeCare shares are held by company insiders. Comparatively, 1.8% of Amedisys shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Does the MarketBeat Community prefer ADUS or AMED?

Amedisys received 175 more outperform votes than Addus HomeCare when rated by MarketBeat users. However, 68.67% of users gave Addus HomeCare an outperform vote while only 58.72% of users gave Amedisys an outperform vote.

Company	Underperform	Outperform
Addus HomeCare	Outperform Votes 320 68.67%	Underperform Votes 146 31.33%
Amedisys	Outperform Votes 495 58.72%	Underperform Votes 348 41.28%

Which has higher valuation & earnings, ADUS or AMED?

Addus HomeCare has higher earnings, but lower revenue than Amedisys. Addus HomeCare is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.06B	2.07	$62.52M	$4.37	27.69
Amedisys	$2.24B	1.32	-$9.75M	$2.52	35.71

Does the media favor ADUS or AMED?

In the previous week, Addus HomeCare and Addus HomeCare both had 6 articles in the media. Addus HomeCare's average media sentiment score of 0.70 beat Amedisys' score of 0.41 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Amedisys	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts rate ADUS or AMED?

Addus HomeCare presently has a consensus price target of $131.63, indicating a potential upside of 8.78%. Amedisys has a consensus price target of $100.67, indicating a potential upside of 11.85%. Given Amedisys' higher probable upside, analysts plainly believe Amedisys is more favorable than Addus HomeCare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.89
Amedisys	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Addus HomeCare beats Amedisys on 13 of the 18 factors compared between the two stocks.